文献速递神经创伤神经重症

创伤性脑损伤治疗的新方法:左西孟旦对坏死、凋亡和氧化应激的影响

A New Approach in the Treatment of Traumatic Brain Injury: The Effects of Levosimendan on Necrosis, Apoptosis, and Oxidative Stress.
PubMed 文献 · World Neurosurg · 2022-09-22

本研究在大鼠创伤性脑损伤模型中探讨左西孟旦对坏死、凋亡和活性氧的影响。28只雌性Wistar-Albino大鼠分为4组,伤后1小时或2小时腹腔注射左西孟旦12 μg/kg。结果显示左西孟旦可能通过减少坏死发挥神经保护作用,但不影响凋亡和抗氧化水平,需全面研究进一步阐明。

要点

  • 左西孟旦组坏死细胞数显著低于对照和创伤未治疗组。
  • 左西孟旦未显著改变活性 caspase-3 水平及超氧化物歧化酶水平。
  • 作者认为左西孟旦可能通过减少坏死发挥神经保护作用。

核心结论

  • 左西孟旦可能通过减少创伤性脑损伤中的坏死发挥神经保护作用,且不影响凋亡和抗氧化水平,需全面研究进一步阐明其对创伤性脑损伤的作用。

研究设计与样本

  • 研究纳入28只雌性Wistar-Albino大鼠,体重200-250 g,分为4组、每组7只:对照组(无创伤)、创伤未治疗组(T)、伤后1小时腹腔注射左西孟旦12 μg/kg组(L1)、伤后2小时腹腔注射左西孟旦12 μg/kg组(L2)。

主要发现

  • L1组和L2组坏死细胞数显著低于对照组和T组(分别为P=0.015和P=0.03)。
  • T组、L1组和L2组活性caspase-3水平较对照组显著升高,但这3组间无显著差异(P>0.05)。
  • 超氧化物歧化酶水平结果与活性caspase-3相似。
  • 对照组过氧化氢酶水平显著高于T组和L2组(P=0.045)。
  • L1组和L2组丙二醛活性显著高于对照组(P=0.023)。

局限性

  • 作者指出需全面研究以完全阐明左西孟旦对创伤性脑损伤的作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Traumatic brain injury (TBI) is an essential and common health problem worldwide. Levosimendan is an inotropic and vasodilator drug used to treat heart failure. Moreover, it exerts pleiotropic effects and, thus, protective effects on many organs. The present study aimed to investigate the effect of levosimendan on necrosis, apoptosis, and reactive oxygen species in rats with TBI. METHODS: The study included 28 female Wistar-Albino rats weighing 200-250 g. The rats were divided into 4 groups with 7 rats each as follows: Group 1: No trauma group (Control), Group 2: Traumatized, untreated group (T), Group 3: Levosimendan was administered at a dose of 12 μg/kg intraperitoneally 1 hour after the trauma (L1), Group 4: Levosimendan was administered at a dose of 12 μg/kg intraperitoneally 2 hours after the concussion (L2). After the experiment, the rats were decapitated, and the brain tissue was removed. Necrosis was assessed with Cresyl violet staining, apoptosis was assessed with immunohistochemical analysis, superoxide dismutase and catalase levels were measured with the spectrophotometric method, and malondialdehyde (MDA) levels were assessed by High-Performance Liquid Chromatography. RESULTS: The number of necrotic cells in the L1 and L2 groups was significantly lower than in the K and T groups (P = 0.015 and P = 0.03, respectively). Although the active caspase-3 level was signified considerably in the T, L1, and L2 groups compared to the K group, no significant difference was found among these 3 groups (P > 0.05). The results of superoxide dismutase levels were similar to those of active caspase-3. catalase level was significantly higher in the K group than in the T and L2 groups (P = 0.045). Malondialdehyde activity was considerably higher in the L1 and L2 groups compared to the K group (P = 0.023). CONCLUSIONS: Our results indicated that levosimendan may exert a neuroprotective effect by reducing necrosis in TBI and that levosimendan does not affect apoptosis and antioxidant levels in TBI. Comprehensive studies are needed to elucidate the effect of levosimendan on TBI fully.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Aycan A, Oksuz E, Gonullu E, et al. A New Approach in the Treatment of Traumatic Brain Injury: The Effects of Levosimendan on Necrosis, Apoptosis, and Oxidative Stress. World Neurosurg. 2022. PMID: 36152936. doi:10.1016/j.wneu.2022.09.067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。